OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10
Published December 24, 2025 · Recall initiated: October 31, 2025
Summary
FDA records drug Class II recall D-0234-2026, published December 24, 2025 and initiated October 31, 2025. Recalling firm: Novocol Pharmaceutical of Canada, Inc.; Status: Ongoing; Reported quantity: 1,636 cartons; Lot: Lot: D05004E, expires: 04-30-2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective container: cracked/broken cartridges
What to do
Voluntary: Firm initiated · Letter
Get an email if ORAVERSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ORAVERSE
- Manufacturer
- Novocol Pharmaceutical of Canada, Inc.
- Distributor
- U.S.A. Nationwide
- Lot
- Lot: D05004E, expires: 04-30-2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDACook-Walte, Carbocaine 3% (30 mg/mL), (mepivacaine hydrochloride Injection, USP), packaged in a cartonDecember 24, 2025
- FDABaclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDCDecember 24, 2025
- FDABenco dental Graham CHEMICAL CO., Mepivacaine HCI 3% (30 mg/mL) Injection, [Mepivacaine HCI Injection, USP],December 24, 2025
- FDACisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only,December 24, 2025
- FDAdarby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP],December 24, 2025
- FDAOraVerse (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a box of 10 cartridges of 0.4mg/1.7mLMay 16, 2018
Questions about this recall
Was OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10 recalled?
Yes. FDA published recall D-0234-2026 on December 24, 2025. Reported hazard: Defective container: cracked/broken cartridges
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ORAVERSE.